BioSpace News Archive

Press Releases

Saol Therapeutics Receives Complete Response Letter from FDA for SL1009 (DCA) for the Treatment of Pyruvate Dehydrogenase Complex Deficiency (PDCD)

September 9, 2025
·
3 min read
Press Releases

Remedium Bio Announces Strategic Collaboration With Lilly to Develop Gene Therapies for Obesity and Type 2 Diabetes

September 9, 2025
·
2 min read
Press Releases

New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM

September 9, 2025
·
9 min read
Press Releases

Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand

September 9, 2025
·
5 min read
Press Releases

Tevogen Values TVGN-489 at $9–$11 Billion rNPV, Its First Clinical Product From the Proprietary ExacTcell™ Allogeneic T Cell Platform

September 9, 2025
·
4 min read
Press Releases

Atossa Therapeutics Announces Regulatory Strategy Aimed at Accelerating Development of Low-Dose (Z)-Endoxifen for Breast Cancer Risk Reduction

September 9, 2025
·
10 min read
Press Releases

MadSci Announces $10 Million Oversubscribed Seed Financing to Advance Smart Technology for Neurologic Conditions

September 9, 2025
·
3 min read
Press Releases

I-Mab Announces Acceleration of Givastomig Investment and Leadership Appointments

September 9, 2025
·
8 min read
Press Releases

IDEAYA Biosciences Announces Positive Data From Phase 1/2 Combination Trial of IDE397, a potential first-in-class MAT2A inhibitor, and Trodelvy® in MTAP-Deletion Urothelial Cancer

September 9, 2025
·
6 min read
Press Releases

AMO Pharma Enters into License Agreement with Population Health Research Institute (PHRI) and Venca Research Inc. to Advance Largest-Ever Study in Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

September 9, 2025
·
4 min read